Paramount Skydance has filed a lawsuit against Warner Bros. Discovery after its offer to buy the company was turned down. NBC ...
Food and Drug Administration on Monday declined to approve Atara Biotherapeutics' cell therapy for a rare form of blood ...
MS NOW on MSN
This is so clearly a cover up: Rep. Stansbury blasts Trump admin. for slow-walking Epstein files
We could soon learn a lot more from Congress's ongoing probe of the Epstein files, looming over the Trump Administration. On ...
Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...
Inovio’s upside hinges on INO-3107 for HPV-6/11 RRP with FDA PDUFA Oct 2026, regulatory risk, tight cash, and cheap EV. Check ...
After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco ...
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.comNews Commentary – ...
For centuries, major technological advances have been made based on the need to gain superiority in armed conflict. Beyond ...
Insmed outlines 2026 outlook, highlighting BRINSUPRI expansion, ARIKAYCE revenue guidance and multiple late-stage clinical ...
January 6, 2026 / What if your sandwich wrap could talk? Not in a horror-movie way - more like, "FYI, I was recycled, ...
Baystreet.ca News Commentary – The war on cancer is moving into a high-tech era of molecular-guided defense. The genomics in ...
Detailed price information for Kyverna Therapeutics Inc (KYTX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback